Moreover, the inflammatory skin disorder was restored by astilbin treatment characterized by reduced accumulation of both IL‐17‐producing T cells and expression of psoriasis‐specific cytokines in skin lesions via downregulation of myeloid differentiation factor 88 (MyD88). The gene discussed is IL17A; the disease is psoriasis.